Introduction
Overpopulation of feral domestic cats (Felis catus) is a problem to control in may regions of the world, despite many efforts. In Australia, feral cats have become well established, including remote arid areas. Feral cats have a wide range of prey and severely impact on native biodiversity (Dickman et al. 1993) . For example, feral cats have been shown to be responsible for killing many re-introduced Rufous Hare wallabies (Lagorchestes hirsutus) released in the Northern Territory, and have significant impact on an isolated colony of Rock wallabies (genus Petrogale) in Queensland (Short et al. 1997) . Current control measures include live trapping, shooting, and poison baiting. However, these methods are not effective in the long term and are labour intensive (Saunders et al. 1995 , Short et al. 1997 .
Immunocontraception is an alternative strategy, which offers a more humane approach with possible longer-term efficacy than current methods of control for animal populations. The objectives of immunocontraception are to elicit an effective autoimmune response against components of the reproductive system, which manifest in infertility. An attractive antigen target in females is the zona pellucida (ZP), a matrix composed of several glycoprotein subunits that surrounds the oocyte. This ZP matrix serves several functions including sperm receptivity, prevention of polyspermy and protection of the fertilised oocyte in the initial stages of differentiation (Dean 1992) .
ZP immunocontraception has been studied in many mammalian species including horse (Kirkpatrick et al. 1990) , deer (Miller et al. 2000) , rabbit (Sehgal et al. 1989) , and mouse (Sun et al. 1999 , Rhim et al. 1992 . The Page 3 of 39 immunisation of females against ZP results in the formation of ZP-specific antibodies, which bind to native autologous ZP and offer contraception by blocking sperm binding to receptors. Studies have also shown ovarian distruction, either permanent or temporary, with possible correlation to ZPspecific antibody responses in the pig, rabbit, dog and squirrel monkey (Jones et al. 1992 , Kerr et al. 1999 , Srivastava et al. 2002 , Sacco et al. 1987 ).
In the domestic cat, relatively few studies have been conducted on the suitability of a ZP vaccine strategy. The potential of heterologous ZP as an immunocontraceptive for cats is controversial (Jewgenow et al. 2000) . Despite the wide application of porcine ZP in many species, porcine ZP proteins, although showing homology with feline ZP, have not been suitable for cat contraception due to lack of immune cross-reactivity (Ringleb et al. 2004 , Kaul et al. 1996 . A study using porcine ZP (SpayVac TM ) showed no effect on oestrus cycling or fecundity in cats despite production of high titre anti-porcine ZP antibodies in vaccinates (Gorman et al. 2002) . The ZP of cats is composed of A, B and C protein subunits (Harris et al. 1994) . Feline ZPB is the first zona glycoprotein to be expressed in maturing oocytes (Jewgenow & Fickel 1999) and antibodies directed against a cat ZPB peptide have been shown to inhibited sperm binding and fertilisation in vitro (Ringleb et al. 2004) .
In this study, porcine ZP was compared to feline ZP for suitability as an immunocontraceptive vaccine candidate antigen in domestic cats. DNA vaccines expressing autologous feline ZP A, B and C subunits were evaluated. We report on the immunogenicity of such ZP vaccines in eliciting feline ZP-specific antibodies, ovarian histology and infertility in cats after mating.
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Australia). Briefly, ovaries were passaged through a descending series of molecular sieves and zonae solubilized and concentrated (x 100) using an ultrafiltration cell. The major polypeptide band (55KDa) after gel electrophoresis (Protprep, National Diagnostics inc., GA, USA) corresponded to the reported M r for native porcine ZPB+C (Yurewicz et al. 1987) . This band was dissolved and dialysed for the polypeptide (porcine ZP55) vaccine.
Preparation of native feline ZP
Ovaries from domestic cats (6 months to 2 years) were obtained from a local cat shelter (Shenton Park, Perth, Australia), collected in phosphate-buffered saline (PBS) and stored frozen at -20 o C until processed. The extraction procedure was modified from Jones et al. (1992) . Briefly, ovaries were homogenised and passed through a series of molecular sieves, centrifuged at 1,800g for 12min at 4°C and subjected to three rounds of freezing and thawing. Zonae were centrifuged at 2,500g for 15min, washed and resuspended in water (pH9), heat-solubilised and stored at -20 o C.
Feline ZP A, B and C DNA vaccines
Plasmids containing the full-length sequences for feline ZP A, B and C were obtained courtesy of Dr. Jeff Harris (Zonagen, USA). The feline ZP gene inserts were subcloned into the pkCMVint mammalian expression vector (Vical Inc., San Diego, CA, USA). This vector contains the human cytomegalovirus immediate-early (IE) 1 gene enhancer/promoter and intron A for transcription initiation with the SV40 polyadenylation signal. Sequences of insert genes were verified with GenBank sequences for feline ZP A, B and C (Harris et al. 1994) . Large-scale plasmid preparations were obtained from terrific broth cultures of transformed E. coli (DH-5α) using standard DNA preparation procedures with LiCl precipitation. Plasmid integrity was verified by electrophoresis and DNA concentrations determined by spectrophotometric analysis. Transcription was confirmed by ZP-specific hybridisation with ZP plasmid transfected COS-7 cell supernatant. Expression of ZP proteins was confirmed by immunohistochemical analysis of transfected COS-7 cells with rabbit anti-porcine ZP antibodies, which cross-react with feline ZP (Barber et al. 2001) .
Vaccination protocols
Porcine ZP polypeptide (B+C) purified by electrophoresis in Protoprep synthetic melting gel containing the porcine ZP polypeptide band at 55KDa was emulsified with Freund's complete (primary vaccine) or incomplete (booster vaccines) adjuvant (Sigma Chemical Co., MO, USA). The control group (n=5) received blank Protoprep gel (without porcine ZP) whereas the vaccine group (n=5) received the porcine ZP55 preparation (75µg polypeptide) at weeks 0, 4, and 8. Cats were immunised subcutaneously, in the dorsum of the neck, over four sites (100µL/site) to minimise scratching of the injection sites.
Feline ZP DNA vaccines were injected into the gastrocnemius and semitendinosus muscles of the hind leg of cats, using an insulin syringe. Cats in the control group (n=8) were injected with the blank pkCMVint vector without ZP gene inserts dissolved in saline (400µg DNA/cat over four injection sites). The ZPA vaccine group (n=7) was immunised with 400µg of the plasmid containing the full-length feline ZPA gene dissolved in saline. The ZPB+C vaccine group (n=5) was immunised with separate plasmids (400µg of each construct) containing the full-length feline ZPB and ZPC genes dissolved in saline (total 800µg DNA/cat). Two booster vaccinations were similarly given at one-month intervals.
Blood collection
Blood samples were obtained by jugular or cephalic venipuncture at fortnightly intervals post primary immunisation, and prior to euthanasia. Plasma was collected from EDTA vacutainers (Becton Dickinson, NJ, USA).
ELISA
Soluble-isolated porcine and feline ZP (1µg/µL) were used as coating antigens diluted in carbonate buffer and incubated overnight at 4°C. Nonspecific antibody binding sites were blocked with 5% skim milk in PBS for 1h at 37°C. Primary antibody was diluted (1:10 or 1:100 in duplicate) and incubated for 1h at 37°C. Wells were washed three times using PBS with 0.1% skim milk/0.05% Tween-20 after all antibody reactions. Rabbit anti-cat IgG (Nordic Immunology, Netherlands, 1:2000) and goat anti-rabbit IgG (H+L) conjugated with horseradish peroxidase (Sigma Chemical Co., MO, USA, 1:3,500) were incubated for 1h at 37°C. TMB One substrate solution (Promega Corp., WI, USA) was developed for up to 10min at room temperature and stopped with 1M HCl (50µL/well). Absorbancies were read at 450nm using a spectrophotometer (Bio-Rad Model 680, CA, USA.
Absorbancies from vaccinated cat sera that were greater than the mean OD+3 SD of control cat sera were considered positive. Rabbit anti-porcine ZP serum was used as a positive control (endpoint titre of 1:13,600).
Mating trials
Female cats were mated after week 11 post-vaccination. The cat reproductive cycle was monitored through observation of behavioural changes indicative of impending oestrus, including changes in the call sounds, rolling motions, increased scent-marking, positioning of the body and head when grasped in a mating hold, and increased interest of the male to the female. Mating was arranged by introducing a single female to a male for one to three mates per day, over three consecutive days. Mating was confirmed by visual observation and post-coital behaviour in the female. Initial determination of pregnancy was made by abdominal palpation at 2-3 weeks post-coitus with confirmation by ultrasound examination at 4-6 weeks. If the queen and litter were to be euthanased before parturition, an overdose of sodium-pentobarbitone was given no later than 6 weeks. If the queen was to carry the litter to term, she was segregated from non-pregnant females. A littering box was provided for birthing. Litter details were recorded as number of live births (average ± SEM).
Queens were euthanased once the kittens had weaned.
Immunohistochemistry
Ovaries were kept in cold PBS until placed in 10% buffered formalin and embedded in paraffin prior to sectioning (4µm) for immunohistochemical analysis. Antigen retrieval was achieved by heating (15-30min) in 50mM citric acid (pH6) for the porcine vaccine trial or Tris/EDTA/sucrose buffer (10mM Tris; 1mM EDTA; 1%sucrose, pH 9) for the feline ZP DNA vaccine trials.
Briefly, endogenous peroxidase activity was quenched with H 2 O 2 . Tissue sections were incubated for 1h with 1% BSA/5% normal goat or horse serum.
Primary cat antibody (1:100) or rabbit anti-porcine ZP antiserum (1:150) was incubated for 1.5h at room temperature. Rabbit anti-cat antibody and then goat-anti-rabbit IgG conjugated to HRP, were applied for 1.5h at room temperature and developed with 3,3'-diaminobenzidine substrate (DAB, Sigma Chemical Co., MO, USA) for 10min. Slides were counterstained with haematoxylin (Dako, Botany, Australia) and viewed using light microscopy.
Histological Analysis of Ovarian Tissue
Follicle populations at different stages of development including primary, secondary, tertiary follicles, and atretic follicles were counted in cat ovarian sections that had been fixed in 10% buffered formalin, embedded in paraffin and stained with haematoxylin and eosin. An oocyte with a single layer of granulosa cells was termed a primary follicle. Growth of surrounding granulosa cells was used to characterise secondary follicles. Progression of the secondary follicle with an antrum was used to characterise tertiary follicles. In addition, evidence of corpora lutea was noted. Primordial follicles are not presented.
Statistical Analysis
Statistical differences for the ovarian histology were assessed by students ttest assuming unequal variances with P values <0.05 considered significant.
Significance of the conception rates from the vaccine groups of the mating trials was assessed by the two-tailed Fisher's exact test with P values<0.05.
Results

Antibody responses of porcine ZP55-vaccinated cats
Serum antibody responses against soluble-isolated porcine ZP were assessed by ELISA in porcine ZP55 polypeptide (B+C) vaccinated cats (Fig.   1a) . Sera from pre-bleeds of all cats were non-reactive against porcine ZP. No circulating antibody to porcine ZP was detected in the control group at any time point for the duration of the study. In contrast, within two weeks postvaccination, a few of the porcine ZP55-vaccinated cats (2/5) had generated a detectable antibody response, which then declined at week 4. However, all porcine ZP55-vaccinated cats (5/5) produced an antibody response following the booster vaccination (week 4), which was observed out to week 10. One individual displayed strong antibody reactivity, which was a greater level than the enpoint titre for the rabbit anti-porcine ZP positive control serum (1:13,600). Furthermore, porcine ZP55-vaccinated cats developed circulating antibodies recognising a 55KDa component of soluble-isolated porcine ZP as assessed by Western blot, indicating ZP polypeptide seroconversion (data not shown).
Next, the ability of porcine ZP55 vaccination to elicit antibodies crossreactive to native feline ZP was investigated by immunohistochemical analysis using normal ovarian tissue from non-experimental cats. Rabbit anti-porcine ZP antibodies cross-reacted specifically against feline ZP of healthy late primary through to antral (Fig. 1b, top) and atretic follicles. Cross-reactivity with the ooplasm but not the primordial oocytes was observed. In contrast, immune sera (week 10 post-vaccination) from porcine ZP55-vaccinated cats showed no evidence of cross-reactivity to feline ZP in ovarian tissue by Page 12 of 39 immunohistochemistry (Fig. 1b, bottom) . Moreover, no endogenous IgG binding to feline ZP in the ovaries was observed in situ by immunohistochemistry, at post-mortem of the porcine ZP55 polypeptidevaccinated cats (Fig. 1c, top) . Sera from week 0 and week 10 post-vaccination of cats in the control group did not display antibody reactivity to feline ZP (Fig.   1c, bottom) .
Fertility of porcine ZP55-vaccinated cats
Cats were mated to assess affects of porcine ZP vaccination on fertility. Signs of oestrus were observed in varying degrees in all cats, including increased affection, calling and positioning. Only four of the five control queens mated and three became pregnant (75% conception rate) with litters ranging from 2-4 live births (Table 1) . One control cat was pseudopregnant, displaying initial characteristics of pregnancy but did not deliver a litter. All five porcine ZP55-vaccinated cats mated. Four of these vaccinated cats became pregnant (80% conception rate) with litter sizes ranging from 2-5 kittens, whilst the other vaccinated cat had histological evidence of ovulation but was pseudopregnant. There were no significant differences between the vaccinated and non-vaccinated mated cats (P=1.00). Also, antibody titres to porcine ZP, as assessed by ELISA, did not correlate with fertility outcomes of individual cats.
Ovarian histology of porcine ZP55-vaccinated cats
Ovaries from porcine ZP55-vaccinated and control cats were assessed postmortem for structural changes (Fig. 2a) . Queens were allowed to litter and ovaries were removed post-mortem after kittens were weaned. Both control and porcine ZP55-vaccinated cats (n=5 per group) revealed normal follicles ranging from early to antral stages, with evidence of ovulation in the form of corpora lutea. However, the porcine ZP55-vaccinated cats had a significantly higher proportion of tertiary follicles than the control group (P<0.05). Feral cats were also assessed for follicle distributions (Fig. 2b) . Adult feral cats (n=8) showed a significantly higher proportion of primary follicles than juvenile feral cats (n=6, P<0.05). Overall, the distribution of follicle populations was found to be similar between experimental and adult feral cats except for a significantly smaller proportion of corpora lutea in the feral cats (P<0.05).
Antibody responses of feline ZP DNA-vaccinated cats
Next, cats were vaccinated with either feline ZPA or a combination of feline ZPB and ZPC, delivered as DNA vaccines. Antibody responses against solubilised feline ZP were assessed by ELISA using pooled sera. Cats vaccinated with feline ZPA showed low titres of antibodies to feline ZP, peaking at week 4 (1.5 log 2 , Fig. 3a) . Whereas, antibodies against feline ZP were not apparent in the feline ZPB+C DNA-vaccinated group until week 11, being three weeks after the second boost (1.5 log 2 ). No circulating antibodies to feline ZP were detected in the control group at any timepoint.
There was no evidence of serum antibody binding to feline ZP in normal ovarian follicles from control ( Fig. 3b top, Fig. 4a top) , feline ZPA (Fig. 3b bottom) and feline ZPB+C DNA-vaccinated groups (Fig. 4a bottom) .
Examination of antibody binding in situ in feline ZP DNA-vaccinated cats was carried out post-mortem using immunohistochemistry. IgG antibody was bound to the ZP matrices of oocytes from all healthy follicles from the late primary/early secondary stage of folliculogenesis in feline ZPA and ZPB+C DNA-vaccinated cats (Fig. 3c bottom, weeks 19-25 post-vaccination; Fig 4b, weeks 24-32 post-vaccination, respectively). Relative to the level of antibody binding of rabbit anti-porcine ZP antiserum (1:4,000 dilution) to cat ovarian tissue, 3 feline ZPA vaccinated cats showed strong antibody binding. In the feline ZPB+C vaccinated group, 2 cats displayed moderate, 2 cats displayed weak, whilst 1 cat showed very weak levels of in situ antibody binding to feline ZP in the ovaries. Collapsed ZP matrices from atretic follicles were more intensely stained for antibody binding relative to ZP from healthy follicles (Fig.   4b ). In contrast, healthy follicles of control cats (n=8) were clear of antibody binding (Fig. 3c top) .
Fertility of feline ZP DNA-vaccinated cats
Conception rates of feline ZP DNA-vaccinated cats were next examined (Table 2 ). In the control group comprised of 8 cats, 7 mated with evidence of corpora lutea in ovaries and became pregnant with litter sizes of 2-5 kittens born, representing a 71% conception rate. When considering the total number of cats in the control group (n=8), the conception rate was 62% with an average litter size of 2 kittens. The one control cat, that did not mate, actively rejected the male and did not show signs of corpora lutea in the ovaries.
Of the 7 feline ZPA DNA-vaccinated cats, 4 mated with production of only one litter of 2 kittens, representing a conception rate of 25% in mated females.
However, the reduction in conception rate compared to the control group did not achieve significance due to low sample sizes (P=0.24). Indeed, the conception rate was further reduced to 14% (P=0.12) with an average litter size of 0.3 kittens when adjusted for total number of ZPA-vaccinates (n=7).
One ZPA-vaccinated cat had evidence of five empty sacs in the uterine horns at post-mortem, with small nodules of tissue distinguishable from the surrounding uterine wall in the sacs, suggesting foetus resorption. The ovaries appeared normal, with prominent corpora lutea. Two of the other ZPAvaccinated cats became pseudopregnant, displaying torsioned and enlarged uterine horns with corpora lutea in the ovaries. Three vaccinated cats actively rejected the male and refused to mate. One of these cats did not show evidence of corpora lutea. Interestingly, the other 2 cats revealed reproductive anomalies, including very small and underdeveloped ovaries with no discernable follicular structures. In one of these cats, the corpora lutea were not evident. However, the uterine horns did not appear grossly abnormal. In the remaining cat, the uterine horns were very thin and translucent. Ovarian structures were translucent and vestigial in appearance and size.
In the feline ZPB+C DNA-vaccinated cat group (n=5), all 5 cats successfully mated with only one cat becoming pregnant and delivering a litter of 2 kittens, representing a conception rate of 20%. However, due to the small sample sizes, the reduction in conception was not statistically significant (P=0.24). The difference between adjusted conception rates of 20% for the vaccinated group and 62% for the controls, when using the total number of cats in each group, was also not significant (P=0.26). There was one incident of pseudopregnancy in the feline ZPB+C DNA-vaccinated group.
Ovarian histology of feline ZP DNA-vaccinated cats
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Examination of post-mortem ovarian tissue from experimental cats showed normal histology despite feline ZP DNA-vaccination. Numbers of primary, secondary and tertiary follicles, corpora lutea and atretic follicles were recorded (Fig. 5) . Follicle cell subpopulations were expressed as a proportion of the total follicle population to account for any differences in ovary size between individuals. There were no significant differences (P>0.05) in either the cell subpopulation distribution or total number of follicles between control and feline ZP DNA-vaccinated cats, regardless of ZPA or ZPB+C vaccination.
The distribution of primary follicle cell subpopulations in these feline ZP DNAvaccinated cats was found to be similar to that observed in juvenile feral cats and significantly less than that found in adult feral cats (P<0.05).
Note, that the ovaries of two feline ZPA DNA-vaccinated cats were vestigial and underdeveloped with no recognisable follicular structures or oocytes.
However, no significant antibody binding to ovarian tissue in these cats was observed by in situ immunohistochemical analysis and no inflammation was evident (data not shown).
Discussion
Control of feral cat populations is a pertinent issue in many parts of the world, including Australia, as feral cats are regarded as significant predators to wildlife. Immunocontraception using ZP proteins offers a humane approach to population control of pest animals. Few studies on the potential of immunological contraceptives in the domestic cat have been performed, despite large research efforts in other species, including wild deer and horse in North America (Miller at al. 2000 , Willis et al. 1994 , seals (Brown et al. 1997) and African elephants (Fayrer-Hosken et al. 2000) . Here in this study, we have examined both heterologous porcine ZP and autologous feline ZP antigens as candidate vaccines for immunocontraception in the domestic cat.
In cats that were mated, vaccination of female domestic cats with three doses of porcine ZP55 polypeptide in Freund's adjuvant failed to elicit detectable antibody responses to feline ZP as assessed by immunohistochemistry, despite the production of antibodies to porcine ZP55.
These results concur with the absence of antibody cross-reactivity between porcine ZP and cat ZP (Gorman et al. 2002) . Furthermore, there was no evidence of ovarian pathology and no significant reduction in fecundity following mating of the porcine ZP-vaccinates (P=1.00). In contrast, vaccination of cats with plasmid vectors expressing autologous feline ZPA and ZPB+C subunits induced low levels of circulating antibodies to feline ZP. conception rate compared to controls with fertility rates of 83%. We acknowledge that the sample sizes for the fertility outcomes are small as not all females (sham or ZP-vaccinated) accepted the male and mated during the experimental study. Also, an outbred population of animals may give variable responses to ZP DNA vaccination and further vaccine trials are warranted.
Nonetheless, our studies demonstrate the immunocontraceptive potential for feline ZP subunits as candidate vaccine antigens for domestic cats.
There is increasing evidence that soluble-isolated whole porcine ZP, despite being efficacious for immunocontraception in various species, is not suitable for either domestic or exotic felid species, possibly due to lack of feline antibody cross-reactivity (Harrenstein et al. 2004) . Functional studies comparing feline ZPB with that of other species has shown that regions unique to feline ZPB appear to play a significant role in fertilisation and sperm binding. Thus the failure of porcine ZP as an immunocontraceptive antigen appears to be due to lack of cross-reactivity of feline anti-porcine ZP antibodies with native feline ZPB epitopes. While ZP with sperm receptor function have been the major focus of immunocontraceptive research, studies using porcine ZP in various species have shown that all ZP subunit proteins have contraceptive potential (Aitken et al. 1982 , East et al. 1985 , Henderson et al. 1988 , Jewgenow et al. 1994 . Cynomolgus monkeys vaccinated with recombinant human ZPA or C proteins were fertile, whereas vaccination with human ZPB resulted in infertility that was irreversible and associated with cycle disruptions (Martinez & Harris 2000) .
Furthermore, heterologous ZP DNA constructs (recombinant dog ZP3 and bonnet monkey ZPB) have been used to immunise mice (Rath et al. 2002 (Rath et al. , 2003 . Antibodies were produced that cross-reacted with recombinant ZP protein and native ZP in ovarian tissue of DNA-vaccinated mice, which inhibited sperm binding in vitro. Another study examined the ability of a truncated rabbit ZPC DNA construct to generate an immune response in female rabbits (Xiang et al. 2003) . Female rabbits developed an antibody response capable of recognising native ZP in ovarian tissues, with no associated changes to ovarian structure. However, no effects of such ZP DNA vaccination of rabbits on fertility in vivo were reported. However, studies on immunocontraception in model species, for example mice, rabbits and monkeys, are not readily transferable to felid species.
ZP derived from several other species has been investigated in a cat study (Levy et al. 2005) . Cats vaccinated with soluble ZP encapsulated in liposomes and emulsified in Freund's or alum adjuvant, showed that mink ZP was better than ferret, dog and feline ZP at inducing cross-reactive anti-feline ZP antibodies. However, mating trials at 20 weeks post-single vaccination showed that all cats (n=3/group) became pregnant with normal litter sizes (4 kitten/litter). Therefore, fertility was not impeded by ZP vaccination using this protocol. Several ZP immunisation regimes have been shown to affect ovary structure and function, which may or may not manifest as infertility (Bagavant et al. 1999 , Mahi-Brown et al. 1988 . It has been reported that ovarian damage is associated with CD4 + T cell epitopes on the immunising antigen (Lou et al. 1995) . However, oophoritis does not necessarily lead to infertility (Bagavant et al. 1999) . Vaccination with a T cell epitope that drives a Th1 response has been shown to induce autoantibodies against native ZP (Lou & Tung 1993 , Lou et al. 1996 . 
